Utah Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 8 (62% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 2,290
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 62.65%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 732
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 71.11%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 33.45% 26.64%
White, Hispanic/Latino Patients 44.50% 51.09%
Black/African American, Non-Hispanic/Latino Patients 0.74% 0.68%
Black/African American, Hispanic/Latino Patients 0.13% 0.14%
Asian Patients3 0.26% 0.27%
American Indian/Alaska Native Patients3 0.66% 0.41%
Native Hawaiian/Other Pacific Islander Patients3 0.61% 0.68%
Patients with More Than One Race3 5.46% 4.10%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.76% 8.20%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.02% 1.37%
Unreported/Refused to Report Race and Ethnicity 6.42% 6.42%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 476
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 75.87%
COVID-19 Immunization Series Completed 302
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 77.54%
COVID-19 Immunization Series Additional 588
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 71.00%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 23.32% 21.19% 27.72%
White, Hispanic/Latino Patients 51.89% 53.97% 48.13%
Black/African American, Non-Hispanic/Latino Patients 2.10% 0.66% 1.53%
Black/African American, Hispanic/Latino Patients 0.00% 0.00% 0.00%
Asian Patients3 0.42% 0.33% 1.02%
American Indian/Alaska Native Patients3 1.26% 0.66% 0.85%
Native Hawaiian/Other Pacific Islander Patients3 0.42% 0.99% 1.19%
Patients with More Than One Race3 12.82% 13.25% 10.54%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.41% 3.31% 4.59%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.47% 2.65% 1.70%
Unreported/Refused to Report Race and Ethnicity 1.89% 2.98% 2.72%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 37.50%
1 to 24 Hours 25.00%
More Than 24 Hours 37.50%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 50.00%
Vaccine confidence 25.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 25.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 37.50%
Average Percent of Health Center Visits Conducted Virtually 9.38%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 12.50%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 6
Number of School-Based Vaccination Sites 0
Number of Family Vaccination Clinics 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 62.50%
None 37.50%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 37.50%
Patient awareness/education 0.00%
Staffing capacity 0.00%
Therapy administration/onsite logistics 0.00%
Other 0.00%
None 62.50%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 1
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 10,435

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 100.00%
Provide to General Public Who Came to the Health Center 100.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 0.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 0.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022